On August 7, 2023, the United States Food and Drug Administration (FDA) provided the cosmetics industry with much-needed clarity through its Draft Guidance on Registration and Listing of Cosmetic Product Facilities and Products. Open for review and public comment, the Draft Guidance aims to elucidate the registration and listing prerequisites that cosmetics companies will soon need to comply with under the Modernization of Cosmetics Regulation Act (MoCRA). This act was signed into law back in December 2022.
Speaking in broader terms, MoCRA made noteworthy amendments to the existing regulations pertaining to the cosmetics industry. Consequently, these changes posed new challenges to the entities operating within the sector. Compliance with the updated regulations necessitated an acute understanding of the changes brought about by MoCRA. This is where the new Draft Guidance from the FDA comes into play.
The Draft Guidance will act as a comprehensive reference for industry professionals aiming to navigate the modified landscape. Detailed provisions regarding the registration of cosmetic product facilities, the listing of cosmetic products, and other related processes are included within the guidance.
This development signals yet another step in the ongoing modernisation of cosmetics laws and regulations. However, it’s crucial for industry experts and legal representatives to thoroughly understand and adhere to the changes suggested in the Draft Guidance to stay on the right side of the law and to ensure smooth business operations.